Stock Updates

Today’s Large Cap Details for Teva Pharmaceutical Industries Limited (NYSE: TEVA) of Drug Manufacturers – Other

Teva Pharmaceutical Industries Limited (NYSE: TEVA), is firmly in the large market cap category with market cap of 33.72 B. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Teva Pharmaceutical Industries Limited is 31.47 (with a change from open of 0.00%), this in conjunction with a target price of 36.95. Volume today has so far reached 41450, with an average volume of about 8135.99. The GAP for this stock, is -1.35%.

The P/E ratio is 300.94, bringing the forward P/E to a value of 6.76. The current EPS for Teva Pharmaceutical Industries Limited, is 0.11, with a EPS growth for this year coming to a value of -96.10%. Performance has been interesting with performance year to date coming to -12.00%.

Looking further into the growth statistics for Teva Pharmaceutical Industries Limited, EPS is looking like it will grow -1.32% in the next year. Looking even further it is projected to be 2.83%. Quarter over quarter is -8.00% for EPS growth and for sales growth quarter over quarter it is 17.00%. Looking at past EPS growth statistics we see that for the past five years it has been -53.00%. Sales growth for the past five years has in fact been 3.60%.

Looking at the ownership, we see that the insider ownership is at 2.70% and institutional ownership is 59.00%. Shares outstanding is 1057.15, while shares float is at a value of 912.42. Float short for Teva Pharmaceutical Industries Limited is 4.16% and the short ratio is 4.66.

In terms of debt, long term debt/equity is 1.08, while the total debt/equity comes to 1.14. The ability to meet these debts, means that the current ratio is 0.9, and the quick ratio is 0.6. The most recent gross margin is 52.30% and their operating margin is 8.30%. The profit margin is 0.30%.

Teva Pharmaceutical Industries Limited has seen returns on assets of 0.10%, and on investment, 1.10%. Return on equity is 0.30%. Price/Earnings to growth ratio is 106.27. Price/Sales ratio is at a value of 1.48, with Price/book ratio coming to 1.07 and Price/cash is 36.98, and finally Price/Free cash Flow is 16.48.

The simple moving averages are -2.03% and -10.22% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -43.59% and the 52 week low is 14.04%.

Teva Pharmaceutical Industries Limited has a dividend yield of 4.26%, with a current price of 31.47. The ability to pay this means the payout ratio is *TBA. This is in an industry, Drug Manufacturers – Other, with equally high dividends from other companies in this sector, which it is Healthcare. Teva Pharmaceutical Industries Limited is based in Israel.

Performance in the Drug Manufacturers – Other industry means that Teva Pharmaceutical Industries Limited has seen performance for the past week of 1.14%, with performance for the month coming to 4.01%. Looking at the data for the quarter it is at a value of -0.50%, and for the half year the performance is -41.98%. Volatility for this week is 3.67% and for the month this is 2.89%.

TEVA

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment